CLINICAL_TRIALS
trial_result
· 2016-05-09
Clinical Trial Update: LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris [Phase 3]
Summary
A Phase 3 trial evaluating LEO 90100 versus vehicle in psoriasis vulgaris has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: LEO Pharma | Conditions: Psoriasis Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2016-05-09